Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
HKEX:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Stock Forecast & Price Target
0 Followers
See the Price Targets and Ratings of:
2315 Analyst Ratings
Currently, no data available
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
2315 Stock 12 Month Forecast
There Are No Analyst Ratings for HK:2315 In The Last 3 Months.
| Highest Price Target― | Average Price Target― | Lowest Price Target― |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
2315 Financial Forecast
Detailed List of Analyst Forecasts
CMB International Securities
HK$22.36
Buy
192.29%
Upside
Reiterated
08/29/23
We expect the Company to break even in 2025. Biocytogen had a cash balance of RMB551mn.
Best Analysts Covering Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
Which Analyst Should I Follow If I Want to Buy HK:2315 and Sell After:
1 Month
3 Months
1 Year
Success Rate
0/1 ratings generated profit
Average Return
-53.20%
reiterated a buy rating 10 months ago
Copying Jill Wu's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -53.20% per trade.
2 Years
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
2315 Analyst Recommendation Trends
Rating
Aug 23
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
total
1
Each month's total comprises the sum of three months' worth of ratings.
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
2315 Stock Forecast FAQ
What is HK:2315’s average 12-month price target, according to analysts?
Currently, no data Available
What is HK:2315’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for HK:2315, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H a Buy, Sell or Hold?
Currently, no data Available
What is Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H’s share price target?
Currently, no data Available
What do analysts say about Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H?
To buy shares of HK:2315, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.